SAN FRANCISCO, June 2, 2025 /PRNewswire/ — Rad AI, the leading generative AI platform for radiology, is pleased to announce Demetri Giannikopoulos as Chief Growth Officer. In this role, Demetri will drive Rad AI’s go-to-market strategy, deepen relationships with health systems, and help scale AI-powered clinical solutions that are already transforming workflows across more than 40% of U.S. health systems.
Demetri brings over 20 years of experience in healthcare technology, with a track record of advancing AI adoption in complex clinical settings. Most recently, he served as Chief Transformation Officer at Aidoc, where he led large-scale implementation of AI in radiology, cardiology, and critical care.
A leader in responsible AI deployment, Demetri has contributed to national guidelines like BRIDGE and serves as a workgroup member for the Coalition for Health AI. His personal commitment to patient-centered care is reflected in his roles on the ACR Patient & Family Centered Care Quality Experience Committee and as a Patient-Centered Outcomes Research Institute (PCORI) Ambassador.
“Demetri’s ability to bridge policy, practice, and patient-centered innovation makes him uniquely qualified to guide our growth,” said Doktor Gurson, CEO of Rad AI. “He understands both the complexity of clinical integration and the urgency of scalable, ethical AI adoption.”
Rad AI’s solutions are currently utilized by over 40% of U.S. health systems, including 9 of the 10 largest radiology practices, streamlining workflows, ensuring timely patient care, and continue to lead in responsibly shaping the future of clinical AI.
For more information about Rad AI and its leadership team, visit www.radai.com.
About Rad AI
Rad AI is the leader in generative AI solutions for radiology, transforming the way radiologists work and improving patient care. The company’s flagship product, Rad AI Reporting, streamlines radiology reporting with AI-driven technology and empowers radiologists to achieve greater efficiency, accuracy, and satisfaction. Rad AI Impressions, the company’s pioneering product, established Rad AI as an innovator in generative AI for radiology; as the first generative AI application to achieve widespread adoption in radiology, it is now trusted by thousands of U.S. radiologists. Rad AI Continuity, the most comprehensive solution of its kind, provides AI-driven patient follow-up.
Rad AI is the fastest-growing radiologist-led AI company and has been recognized as one of the most promising healthcare AI companies by CB Insights (Digital Health 50, AI 100) and AuntMinnie (Best New Radiology Software). Rad AI was named the 19th fastest-growing company in North America on the Deloitte Fast 500. Most recently, in April 2025, Rad AI was named the 4th fastest-growing private company on the Inc. Regionals Pacific list.
Learn more about Rad AI at www.radai.com or on LinkedIn at www.linkedin.com/company/radai/
PR Contact: Wei Ting Hsieh, Rad AI, weiting.hsieh@radai.com
SOURCE Rad AI
An In-Depth Analysis of Digital Sound Frequency Programs, Binaural Beats Research, and Key Considerations for…
Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research…
The Best SARMS for Strength, Cutting, Muscle Growth, Body Building & Recovery - A Guide…
Ozempic for Weight Loss: Does It Work and Is It Safe? Read PhenQ Details –…
Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know Before…
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…